Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
Tasnia Tarana, Medical and Scientific Illustrator at TaraJuhans, shared a post on LinkedIn:
“1 in 5 women who see a doctor for heavy periods actually have an undiagnosed bleeding disorder.
Not a gynecological one. A blood one.
Part 4 of 4. The finale. The first three parts zoomed in, the full map, the tube, the ovary.
This last piece zooms all the way out. Everything above the uterus in this illustration is doing one job: showing that gynecological symptoms dont always start in the uterus.
- Thyroid disorders affect 1 in 8 women in their lifetime, per the American Thyroid Association, and can throw off a cycle long before anyone checks the uterus
- Liver impairment changes how the body clears estrogen, which can directly affect bleeding patterns
- Psychological stress can suppress the signal from brain to ovaries, stopping ovulation entirely
- An undiagnosed bleeding disorder, per CDC data, shows up in roughly 1 in 5
women evaluated for heavy menstrual bleeding
Thats the point of this final piece: the uterus is often where the symptom shows up, not where the cause lives.
As the illustrator across all four of these, it was never to diagnose anything! thats for an endocrinologist, hematologist or gynecologist, depending on where the cause actually sits.
My job was to map how connected this system really is, panel by panel.
4 posts, 1 organ and the body around it that quietly runs the whole thing.
Groups like the American Thyroid Association, Inc. (ATA), Centers for Disease Control and Prevention, National Bleeding Disorders Foundation and American College of Obstetricians and Gynecologists (ACOG) all work on different pieces of this same picture.
Which connection in this image surprised you most?”
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series